Dr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women’s Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.
Dr. McCabe joined the University of Washington Medical Center in 2013 and became medical director of the Cardiac Cath Labs in 2015. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. He has an active practice in aortic valve disease, all forms of coronary artery blockage, and cardiogenic shock. He is a nationally recognized clinician educator and investigator in coronary artery intervention, and transcatheter therapies for aortic stenosis and cardiogenic shock. His research interests focus on quality and performance metrics for cardiovascular procedures and their use in public ‘report cards’ as well as variations in care provided across institutions and regions. He has been the site principal investigator for several clinical trials and has authored more than 50 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He currently sits on the editorial board of two prestigious cardiovascular journals as well as the management committee for the Cardiovascular Outcomes Assessment Program (COAP), the Washington state public reporting agency for percutaneous coronary interventions where he was formerly chair of the PCI Analytics and Reporting Subcommittee. He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology by Seattle Met Magazine.